Searched for
BAYER PHARMACEUTICAL INVESTMENT INDIA
Jubilant Pharmova eyes $150 million through rupee debt sale, bankers sayJubilant Pharmova plans to raise around Rs 14 billion ($150 million) through a three-year rupee bond offering to fund capital expenditure a...- From nasal delivery to sterile injectables: Biodeal Pharmaceuticals’ expansion plansBiodeal Pharmaceuticals is set to broaden its horizons with a state-of-the-art sterile injectables plant in Himachal Pradesh. This venture ...
- Piyush Goyal discusses investment opportunities with Bayer, FreseniusPiyush Goyal held meetings with Bayer and Fresenius executives to discuss investment opportunities in India's healthcare sector. During the...
- ETMarkets Smart Talk: Smallcap investors should consider a five-year SIP horizon amid volatility: Sorbh GuptaIn an interview with Kshitij Anand of ETMarkets, Sorbh Gupta, Head of Equity at Bajaj Asset Management Limited, says investors considering ...
- 'The problem was caused by you': Commerce Minister Piyush Goyal calls out Europe over carbon emissionsUnion Commerce Minister Piyush Goyal said India accounts for less than 3% of global carbon emissions despite representing 17% of the world'...
- How Vivek Ramaswamy built his billion-dollar fortune through biotech, stock sales and investments — and what he still ownsVivek Ramaswamy's Net Worth: Vivek Ramaswamy’s estimated $2.2 billion to $2.3 billion fortune was built through biotech deals, stock sales ...
- Himadri Speciality Chemicals plans Rs 1,613-cr capacity expansion across key businessesHimadri Speciality Chemicals Ltd is implementing a growth strategy focused on capacity expansion and investment. The company plans to inves...
- Piyush Goyal to explore trade, investment avenues in Germany & NetherlandsCommerce and industry minister Piyush Goyal is set to visit Germany and the Netherlands for trade engagements. He will participate in the B...
- Europe’s last penicillin plant faces a bitter fight against China’s cheaper drugsThe Sandoz penicillin plant in Kundl, Austria, is under threat from cheaper Chinese antibiotic production. European healthcare programs ben...
- India presents a compelling investment proposition for German firms, FICCI saysIndian industry is poised for growth as German companies are encouraged to invest in manufacturing capacities. The upcoming India-European ...
- Sun Pharma to raise Rs 10,000 crore to part-finance Organon dealSun Pharmaceutical Industries plans to raise ₹10,000 crore through two tranches of rupee-denominated bonds. The funds will help refinance b...
- India-New Zealand FTA comes into effect todayThe FTA will provide Indian exporters with 100% duty-free access to the New Zealand market, opening opportunities for MSMEs, women entrepre...
- NATCO Pharma subsidiary launches Carboplatin in US market to address shortagesIndian pharmaceutical company NATCO Pharma annouced the launch of Carboplatin Injection, a generic version of Paraplatin in the US market b...
- Pharma Q2 Outlook: Pricing pressure, US competition to weigh on select playersIndia's pharmaceutical companies are expected to have a mixed performance in the upcoming September quarter. Companies like Sun Pharmaceuti...
- Donald Trump raised stakes in drug companies gaining from medicare exemptions, say DemocratsInvestments in pharmaceutical companies on behalf of Donald Trump saw a significant increase after returning to the White House. His portfo...
- India sixth among major investment partners in Trump's $11.3 trillion US investment push: White HouseUnder Donald Trump's administration, the United States secured USD 11.3 trillion in investments from various countries. Among these, India ...
- Bayer partners with Absolute’s INERA to expand biological crop nutrition in IndiaBayer will market and distribute a biological crop nutrition solution developed by Absolute’s agricultural biotechnology arm INERA, aiming ...
- Bayer’s DirectAcres crosses 2,00,000 acres in IndiaBayer brings together its capabilities in Seeds & Traits, Crop Protection, Digital Farming Solutions and agronomy with tailored mechanizati...
- Assessing products to counter side effects of GLP-1, says Bayer's TrianaBayer AG plans to expand its consumer health business in India significantly by 2030. The company aims to triple its revenue in the Indian ...
- Germany's Bayer to invest $2.2 billion in US pharma siteBayer has announced a significant investment of $2.2 billion to establish a new pharmaceutical site in New Albany, Ohio. This project follo...
Load More
